PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, OH, United States.\', \'Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, OH, United States.\', \'Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, OH, United States. Electronic address: ontaned@ccf.org.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0165-5728(21)00312-X10.1016/j.jneuroim.2021.577785
?:hasPublicationType
?:journal
  • Journal of neuroimmunology
is ?:pmid of
?:pmid
?:pmid
  • 34922126
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.083
?:rankingScore_hIndex
  • 127
?:title
  • New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all